Insulet Stock Earnings Per Share
| PODD Stock | USD 323.24 1.76 0.54% |
Fundamental analysis of Insulet allows traders to better anticipate movements in Insulet's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Insulet Company Earnings Per Share Analysis
Insulet's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Insulet Earnings Per Share | 5.56 X |
Most of Insulet's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insulet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Insulet has an Earnings Per Share of 5.56 times. This is 33.57% lower than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The earnings per share for all United States stocks is 78.21% lower than that of the firm.
Insulet Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insulet's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insulet could also be used in its relative valuation, which is a method of valuing Insulet by comparing valuation metrics of similar companies.Insulet is currently under evaluation in earnings per share category among its peers.
Insulet Fundamentals
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.0694 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 23.29 B | ||||
| Shares Outstanding | 70.37 M | ||||
| Shares Owned By Insiders | 0.28 % | ||||
| Shares Owned By Institutions | 99.72 % | ||||
| Number Of Shares Shorted | 2.28 M | ||||
| Price To Book | 17.19 X | ||||
| Price To Sales | 10.40 X | ||||
| Revenue | 2.07 B | ||||
| Gross Profit | 1.55 B | ||||
| EBITDA | 423.7 M | ||||
| Net Income | 418.3 M | ||||
| Cash And Equivalents | 708.6 M | ||||
| Cash Per Share | 10.21 X | ||||
| Total Debt | 1.39 B | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.69 X | ||||
| Book Value Per Share | 18.91 X | ||||
| Cash Flow From Operations | 430.3 M | ||||
| Short Ratio | 2.56 X | ||||
| Earnings Per Share | 5.56 X | ||||
| Price To Earnings To Growth | 8.21 X | ||||
| Target Price | 332.35 | ||||
| Number Of Employees | 3.9 K | ||||
| Beta | 1.38 | ||||
| Market Capitalization | 22.87 B | ||||
| Total Asset | 3.09 B | ||||
| Retained Earnings | 40.3 M | ||||
| Working Capital | 1.36 B | ||||
| Current Asset | 190.76 M | ||||
| Current Liabilities | 65.16 M | ||||
| Net Asset | 3.09 B |
About Insulet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:Check out Insulet Piotroski F Score and Insulet Altman Z Score analysis. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.